Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Xintela AB
XINTCurrent price
0.32 SEK
-0.024 SEK (-6.90%)
Last closed
0.36 SEK
Company
www.xintela.se
ISIN
SE0007756903
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
238 315 376 SEK
Yield for 12 month
+27.06 %
1Y
3Y
5Y
10Y
15Y
XINT
Xintela AB (publ), a biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy. The company's stem cell products include XSTEM that is in Phase I/IIa clinical development for the treatment of knee osteoarthritis, as well as in clinical study for the treatment of difficult-to-heal leg ulcers, acute respiratory distress syndrome, and other indications; and EQSTEM, which is in preclinical development for the treatment of joint disease in horses. It is also developing antibody-based cancer therapies, such as TARG9 and TARG10, which are in preclinical study for the treatment of triple-negative breast cancer and the brain tumor glioblastoma. It has an agreement with Region Östergötland for GMP process development of cell therapy for burn patients. Xintela AB (publ) was incorporated in 2009 and is based in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 81
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+78 187 SEK
Last Year
–
Current Quarter
+4 011 SEK
Last Quarter
+299 717 SEK
Current Year
-3 696 888 SEK
Last Year
-3 795 130 SEK
Current Quarter
+4 011 SEK
Last Quarter
+299 717 SEK
Key Figures XINT
1 year
3 years
5 years
10 years
EBITDA
-43 457 537 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-229.07 %
PEG Ratio
–
Return On Equity TTM
-1064.94 %
Wall Street Target Price
–
Revenue TTM
381 919 SEK
Book Value
-0.032 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
13800 %
Dividend Yield
–
Gross Profit TTM
2 084 013 SEK
Earnings per share
-0.06 SEK
Diluted Eps TTM
-0.06 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics XINT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History XINT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation XINT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
622.8265
Price Sales TTM
623.9951
Enterprise Value EBITDA
-1.6705
Price Book MRQ
18.9564
Financials XINT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XINT
For 52 weeks
0.21 SEK
0.65 SEK
50 Day MA
0.49 SEK
Shares Short Prior Month
–
200 Day MA
0.33 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart